(2S)-2-(1H-indol-3-yl)pentanoic acid

(2S)-2-(1H-indol-3-yl)pentanoic acid Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name (2S)-2-(1H-indol-3-yl)pentanoic acid
Generic (2S)-2-(1H-indol-3-yl)pentanoic acid
Type
Formula C13H15NO2
Weight Average: 217.2637
Monoisotopic: 217.110278729
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
(2S)-2-(1H-indol-3-yl)pentanoic acid
(2S)-2-(1H-indol-3-yl)pentanoic acid

Innovators Monograph

You find simplified version here (2S)-2-(1H-indol-3-yl)pentanoic acid



https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=24768551
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=99443452
https://www.chemspider.com/Chemical-Structure.25057550.html
https://zinc.docking.org/substances/ZINC000039119680
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/2S3
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid
(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol
2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid
2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
(R)-Atenolol
2-HYDROXY-5-{[(1E)-2-PHENYLETHYLIDENE]AMINO}-L-TYROSINE
{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID
4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID
N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide
(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone
Epstein-Barr virus antibody test
Antibody titer blood test
RBC count
Head MRI
Foot drop
Acid-fast stain
Bile culture
Growth hormone test
Fetal MRI
Sweat Test for Cystic Fibrosis
Metastatic disease has progressed during or following platinum-containing chemotherapy urothelial carcinoma (UC)
Mantle Cell Lymphoma (MCL)
Symptomatic
Convulsions
Neutropenia-related sequelae
recurrent Hemophagocytic Lymphohistiocytosis
Metastatic Rhabdomyosarcoma
Intraoperative Hypertension
Acute Nonlymphocytic Leukemia
Moderate Pneumonia